Pharmaceutical Biotechnology Company Developing Genomics-Proteomics Drugs
Basic Information
Galadeno is a pharmaceutical biotechnology company that develops genomics-proteomics drugs for the treatment of inflammatory, musculoskeletal, and connective tissue diseases.